<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01087385</url>
  </required_header>
  <id_info>
    <org_study_id>EK-Nr. 59/10</org_study_id>
    <nct_id>NCT01087385</nct_id>
  </id_info>
  <brief_title>Troponin T as Risk Stratification Tool in Peripheral Arterial Occlusive Disease</brief_title>
  <official_title>Troponin T as Risk Stratification Tool in Patients With Peripheral Arterial Occlusive Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heart Center Bad Krozingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Heart Center Bad Krozingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study hypothesis: elevated Troponin T is a marker of increased mortality in patients with
      peripheral arterial occlusive disease (PAOD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Troponin T and I are established risk markers in patients with acute coronary syndrome. Only
      recently, troponin I was found to be elevated in patients with acute critical limb ischaemia.
      In another study, troponin I was associated with a higher mortality in patients with chronic
      critical limb ischaemia followed over two years. In a longitudinal study design we intend to
      follow all patients that were treated for symptomatic PAOD (Fontaine stages II-IV) from
      01/2007 to 12/2007 in our department of angiology. Main outcome parameters are death and the
      occurrence of major vascular events and revascularization procedures during follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Death</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction, acute coronary syndrome, percutaneous coronary intervention, stroke, amputation, peripheral revascularization, target limb revascularization, target vessel revascularization</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1000</enrollment>
  <condition>Peripheral Arterial Occlusive Disease</condition>
  <arm_group>
    <arm_group_label>Troponin T elevation</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>No troponin T elevation</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        patients with peripheral arterial occlusive disease (Fontaine stages II-IV)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  symptomatic peripheral arterial occlusive disease

          -  aged &gt;/= 18 years

        Exclusion Criteria:

          -  unstable angina or acute coronary syndrome &lt; 14 days

          -  percutaneous coronary intervention &lt; 14 days

          -  other interventions or disease associated with troponin T release (i.e., acute
             pulmonary embolism, aortic dissection, heart valve replacement, acute heart failure,
             non-ischemic cardiomyopathy, heart surgery, thoracic trauma, endocarditis, myocarditis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Birgit Linnemann, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heart Center Bad Krozingen, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Angiologie, Herzzentrum Bad Krozingen</name>
      <address>
        <city>Bad Krozingen</city>
        <zip>D-79189</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2010</study_first_submitted>
  <study_first_submitted_qc>March 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 16, 2010</study_first_posted>
  <last_update_submitted>April 14, 2015</last_update_submitted>
  <last_update_submitted_qc>April 14, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 15, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heart Center Bad Krozingen</investigator_affiliation>
    <investigator_full_name>Birgit Linnemann</investigator_full_name>
    <investigator_title>Dr. Birgit Linnemann</investigator_title>
  </responsible_party>
  <keyword>peripheral arterial occlusive disease</keyword>
  <keyword>mortality</keyword>
  <keyword>cardiovascular events</keyword>
  <keyword>amputation</keyword>
  <keyword>peripheral arterial revascularization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arterial Occlusive Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

